Clinical Study on Kawasaki Disease for Evidence-based Treatment.
- Author:
Min Seob SONG
1
Author Information
1. Department of Pediatrics, College of Medicine, Inje university, Busan Paik Hospital, Busan, Korea. msped@medimail.co.kr
- Publication Type:Review
- Keywords:
Kawasaki disease;
Treatment;
Evidence-based
- MeSH:
Coronary Aneurysm;
Coronary Thrombosis;
Coronary Vessels;
Evidence-Based Medicine;
Humans;
Infarction;
Inflammation;
Mucocutaneous Lymph Node Syndrome*;
Myocardial Ischemia
- From:Journal of the Korean Pediatric Cardiology Society
2007;11(2):106-111
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Evidence-based medicine is a medical movement combining professional experience with the best scientific research results. Treatment of Kawasaki disease in the acute phase is directed at reducing inflammation in the coronary artery wall and preventing coronary thrombosis, whereas long-term therapy in individuals who develop coronary aneurysms is aimed at preventing myocardial ischemia or infarction. I attempt to summarize the current state of knowledge of the medical management of patients with Kawasaki disease. The recommendations are evidence-based and derived from published data wherever possible.
